(Q24244142)

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Treatment of cancer weight loss in patients with advanced lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Phase III Evaluation of 4 Doses of Megestrol Acetate as Therapy for Patients with Cancer Anorexia and/or Cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Effect of megestrol acetate on weight loss, body composition and blood screen of gastrointestinal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Megestrol acetate in patients with AIDS and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Risk factors relating blood markers of inflammation and nutritional status to survival in cachectic geriatric patients in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Cancer cachexia: a therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

HIV wasting syndrome: treatment update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Clinical management of anorexia and cachexia in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

On appetite and its loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

Megestrol acetate in cancer anorexia and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Management of anorexic patients in radiotherapy: a prospective randomized comparison of megestrol and prednisolone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Effect of megestrol acetate and prepulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Cachexia and cancer: a clinician's view

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Risks and benefits of various therapies for cancer anorexia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Megestrol acetate for cachexia and anorexia in advanced non-small cell lung cancer: a randomized study comparing two different doses.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

The cancer anorexia-cachexia syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021

Megestrol acetate in patients with AIDS-related cachexia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004310.PUB2

7 January 2021